Key Takeaways BrainsWay invested $5M in Neurolief to enter the at-home mental health treatment market.Neurolief's Proliv Rx targets treatment-resistant depression and awaits FDA approval.The deal includes future milestone-based funding and a call option for full acquisition.BrainsWay Ltd. (BWAY) recently took a strategic step to expand its reach in the mental health market through a $5 million investment in Neurolief Ltd., a developer of wearable, non-invasive neuromodulation devices. The investment positio ...

BrainsWay (BWAY) Q2 2025 Earnings Call August 13, 2025 08:00 AM ET Speaker0Day, and welcome to the Brainsway Second Quarter twenty twenty five Earnings Conference Call. All participants will be in listen only mode. Please note this event is being recorded. I would now like to turn the conference over to Garth Russell with Investor Relations from LifeSci Advisors. Please go ahead.Speaker1Thank you all, and welcome to Brainsway's second quarter twenty twenty five earnings conference call. With us today are Br ...